Specialty Dosage Drugs

Jul 18, 2016
By Pharmaceutical Technology Editors
The agency says the increasing requests for orphan drug designation has resulted in a change in FDA’s review goals.
Jun 30, 2016
By Pharmaceutical Technology Editors
The drug received breakthrough therapy and orphan drug designation as a monotherapy for the treatment of chronic graft-versus-host-disease.
Jun 02, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
The company expanded its topicals capacity with an investment in the Becomix RW30 model homogenizer.
May 31, 2016
By Pharmaceutical Technology Editors
The agency publishes draft guidance on assessing the adhesion of transdermal delivery systems and topical patches.
Apr 29, 2016
By Pharmaceutical Technology Editors
The agency found no differences in risk of pneumonia for different products.
Jan 26, 2016
By Pharmaceutical Technology Editors
Novartis announced on Jan. 5, 2016 that the company is collaborating with Qualcomm to develop cloud-based technology for COPD patients.
Jan 05, 2016
By Pharmaceutical Technology Editors
Ionis Pharmaceuticals receives orphan drug designation for HTTRx for the treatment of Huntington’s disease.
Oct 06, 2015
By Pharmaceutical Technology Editors
3M and Impel will collaborate to develop and commercialize Impel’s Precision Olfactory Delivery technology for enhanced central nervous system drug delivery.
Sep 15, 2015
By Pharmaceutical Technology Editors
BASF explains how the selection of excipients in topical semisolid formulations can de- termine the structure of microscopic phases that form during processing.Pharmaceutical Technology magazine recently spoke with Dr. Bozena Michniak-Kohn, Pro- fessor and Director of Center for Dermal Research at Rutgers University, and Norman Rich- ardson, Global Technical Development and Marketing Manager, Skin Delivery at BASF, about the importance of semisolid microstructure and the impact they have on the final formulation.
Sep 08, 2015
By Pharmaceutical Technology Editors
The agency has set up a workshop on how to demonstrate the benefits of orphan drugs over existing treatments.
native1_300x100
lorem ipsum